AMBRILIA ANNOUNCES FISCAL 2005 RESULTS AND APPOINTMENT OF THREE NEW BOARD MEMBERS
Ambrilia Biopharma Inc. (formerly Procyon Biopharma Inc.), a biotechnology company
developing innovative therapeutics in the fields of cancer and infectious diseases,
announced today its fiscal 2005 results and the appointment of three new members
to its Board of Directors.